Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer
Sponsor: The Affiliated Hospital of Qingdao University
Summary
The present study will assess real-world clinical outcomes, adverse events and economics from treatment with endocrine therapy(ET) combined with abemaciclib in patients with hormone receptor-positive(HR+) breast cancer.
Official title: A Retrospective Real-world Study of Efficacy, Safety, and Economic Assessment of Abemaciclib Tablets Based on Hospital Information System(HIS) in Hormone Recepter Positive(HR+) Breast Cancer Patients
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2024-06-01
Completion Date
2025-07-01
Last Updated
2024-05-10
Healthy Volunteers
No
Conditions
Interventions
Abemaciclib and Letrozole/Anastrozole
Take the treatment with Abemaciclib and Letrozole/Anastrozole at the same time.
Letrozole or Anastrozole
Take the treatment with Letrozole or Anastrozole.
Abemaciclib and Fulvestrant
Take the treatment with Abemaciclib and Fulvestrant at the same time.
Fulvestrant
Take the treatment with Fulvestrant only.
Locations (1)
Clinical Research Center
Qingdao, Shandong, China